XNAS

Datos históricos de Rapport Therapeutics, Inc. Common Stock

Rapport Therapeutics, Inc. Common Stock · RAPP

$30.65

▲ +0.03 (+0.08%)

Última operación · 10/10/2026, 18:50:48 UTC

Variación en el periodo
+15.66%
Máximo
US$52.93
27 de agosto de 2026
Mínimo
US$23.75
17 de noviembre de 2025
Volumen medio diario
0.37 M

Del 10 de octubre de 2025 al 9 de octubre de 2026. Precios en dólares, ajustados por splits.

FechaAperturaMáximoMínimoCierreVar.Volumen
9 oct 202629.7331.2029.5030.65+2.68%247,905.16
8 oct 202630.6230.6229.4529.85−3.27%236,779.604
7 oct 202630.8131.3530.4630.86−0.93%314,989.03
6 oct 202632.9234.0030.0131.15−3.23%235,744.034
5 oct 202632.2232.7131.5332.19+0.06%198,868.432
2 oct 202633.3334.4831.7732.17−2.01%277,626.796
1 oct 202633.5234.3232.8032.83−2.29%326,777.222
30 sep 202633.1734.0532.6233.60+1.76%582,026.666
29 sep 202633.2533.6632.1233.02−1.26%626,151.933
28 sep 202633.4834.0032.3633.44−1.39%552,306.76
25 sep 202633.8034.8933.0533.91+0.24%711,808.019
24 sep 202634.1534.2131.5833.83−0.88%848,741.564
23 sep 202641.0141.4733.3834.13−17.70%745,549.214
22 sep 202639.9741.5537.9441.47+4.56%900,214.376
21 sep 202640.7042.1839.1139.66−1.95%616,978.148
18 sep 202641.8943.0040.2940.45−3.58%998,058.545
17 sep 202642.1342.9041.3941.95+1.35%397,300.495
16 sep 202642.8243.6741.2341.39−3.02%387,025.806
15 sep 202643.8743.9841.7642.68−3.00%189,312.657
14 sep 202644.3044.9043.3644.00+0.87%196,927.687
11 sep 202644.2144.3043.0143.62+0.37%251,788.033
10 sep 202643.3544.0042.6543.46−0.97%319,264.553
9 sep 202645.1745.4243.1343.89−4.78%437,739.934
8 sep 202645.0147.0044.6746.09+0.70%489,386.341
4 sep 202647.6348.0045.5245.77−3.95%279,884.884
3 sep 202648.8549.1447.0847.65−2.14%276,962.762
2 sep 202648.5050.3447.7348.69+0.27%294,754.218
1 sep 202648.1749.3847.9048.56−0.23%148,596.199
31 ago 202648.7249.3347.5148.67−0.21%221,024.211
28 ago 202650.1550.6848.3748.77−4.05%332,731.123

Cotizaciones en tiempo real durante el horario de mercado. Fuentes: Massive y Financial Modeling Prep. Esta página tiene fines informativos y no constituye asesoría financiera.